EAST RUTHERFORD, N.J., May 9 /PRNewswire-FirstCall/ -- Cambrex Corporation , a leading provider to the healthcare industry, is pleased to announce the appointment of David DeMarco Ph.D. as Vice President Strategic Planning. Mr. DeMarco will direct the development and implementation of the Company's transformational business strategy as Cambrex moves into the specialty therapeutics market.
(Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO )
"We are very pleased to have Dave join Cambrex," commented John R. Leone, Cambrex President and Chief Executive Officer. "His unique commercial skills, creativity exploring strategic alternatives and experience in the pharmaceutical industry will be beneficial as we advance Cambrex through its natural progression from life sciences to specialty therapeutics." Mr. Leone continued, "The appointment underscores our commitment to the healthcare industry and our mandate to cultivate higher growth and more profitable businesses."
Prior to joining Cambrex, Mr. DeMarco was Global Aesthetic Franchise Leader for Sanofi-Aventis Dermatology where he implemented market strategies that supported the global product line launches. He also served as Commercial Head for Europe.
About Cambrex
Cambrex is a global, diversified life sciences company dedicated to providing products and services to accelerate and improve the discovery and commercialization of human therapeutics. The Company employs approximately 1900 worldwide. For more information, please visit http://www.cambrex.com/.
Since the mid-1990's, Cambrex has helped customers develop their active pharmaceutical ingredients (APIs) more efficiently and cost-effectively. The Company has diagnosed and overcome problems that clients had in their manufacturing processes, provided clinical or commercial quantities of hundreds of pharmaceutical products and provided the analytical, regulatory and other support services that clients need to shorten the time to market. More recently, the Company expanded into the product commercialization arena with sales and marketing services. The combined strength of experience, breadth of products and services and success integrating over twenty acquisitions supports the Company's strategy to move into the specialty therapeutics market.
Photo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGOCambrex CorporationCONTACT: Anne-Marie Hess, Director, Investor Relations & CorporateCommunications, 201-804-3062, or annemarie.hess@cambrex.com
Web site: http://www.cambrex.com/
Company News On-Call: http://www.prnewswire.com/comp/134219.html